Mark Entman

Title: Mark Entman: Innovator in Cardiac Diagnosis and Therapy

Introduction

Mark Entman is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cardiac diagnosis and therapy. His innovative work focuses on the cleavage of serum response factor, which plays a crucial role in understanding cardiac diseases.

Latest Patents

Mark Entman holds a patent titled "Cleaved serum response factor in cardiac diagnosis and therapy." This invention is directed to the cleavage of serum response factor as it relates to cardiac disease. In specific embodiments, failing cardiac tissue is diagnosed in tissues comprising elevated cleavage of serum response factor. Furthermore, heart failure is associated with cardiac myocyte apoptosis as a result of an increase in cleaved serum response factor, particularly by caspases. He has 1 patent to his name.

Career Highlights

Mark Entman is affiliated with Baylor College of Medicine, where he continues to advance research in cardiac health. His work has implications for diagnosing and treating heart conditions, making him a valuable asset in the medical community.

Collaborations

Some of his coworkers include Robert J Schwartz and Lei Wei, who contribute to the collaborative efforts in research and innovation at Baylor College of Medicine.

Conclusion

Mark Entman's contributions to cardiac diagnosis and therapy highlight the importance of innovation in medical research. His work not only enhances our understanding of cardiac diseases but also paves the way for future advancements in treatment.